Prosecution Insights
Last updated: October 04, 2026

Korea Research Institute of Chemical Technology

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

17 pending office actions • 10 art units • 16 examiners • 0 of 17 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days

Analysis

Korea Research Institute of Chemical Technology has 17 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 17 actions are assigned to 16 distinct examiners, showing that the pending matters are being reviewed by many different officials. This distribution of 16 distinct examiners for 17 pending office actions requires the institute to address a variety of examiner styles and technical interpretations. Practitioners must be prepared to navigate these different perspectives across the Biotechnology & Pharmaceuticals portfolio.

The workload is spread across 10 distinct art units, reflecting the technical diversity of the institute's chemical and pharmaceutical research. Tam M Nguyen is the busiest examiner, currently overseeing 2 pending office actions. This makes Tam M Nguyen the examiner responsible for 2 of the 17 total pending matters. The presence of 10 distinct art units indicates that the institute's research falls into many different specialized administrative categories within the USPTO.

With 16 distinct examiners and 10 distinct art units, the prosecution environment is decentralized. The institute must coordinate its strategy across 10 different administrative divisions to ensure consistency. The presence of 17 pending office actions across such an array of examiners and units highlights the complexity of managing this portfolio. Applicants should focus on the specific requirements of each of the 10 distinct art units while addressing the feedback from the 16 distinct examiners involved in the 17 pending office actions. Tam M Nguyen represents a point of overlap with 2 actions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

17
Total Pending OAs
7
Non-Final OAs
7
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
4
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (29%)
10
Medium (59%)
2
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (6%)
§103 only8 (47%)
§102 only1 (6%)
Double-patenting only2 (12%)
Double-patenting + other1 (6%)
Multi-statute (no §101)4 (24%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
59% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
12% of docket
0
Mechanical / Eng
0% of docket
5
Business / Other
29% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, TAM M 2 77.1% +11.6%
SINGH, PREM C 1 59.0% +33.1%
ROBINSON, MIKHAIL O'DONNEL 1 59.2% +42.1%
MISHRA, DEEPA 1 29.3% +35.2%
JARRELL, NOBLE E 1 81.1% +9.7%
MOORE, MARGARET G 1 68.0% +15.2%
YI, CHANGHYUN 1 94.0% +4.1%
NGUYEN, LAUREN 1 54.8% +34.3%
D'ANIELLO, NICHOLAS P 1 68.1% +41.8%
GRIZER, CASSANDRA SENN 1 75.0% +18.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18797480 ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS JARRELL, NOBLE E —
18397073 VERTICAL ORGANIC TRANSISTOR AND METHOD OF MANUFACTURING THE SAME YI, CHANGHYUN —

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18271640 NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF GRIZER, CASSANDRA SENN 9d
17419860 POLYMER COMPOSITE MATERIAL COMPRISING ARAMID NANOFIBER, AND METHOD FOR PREPARING SAME LOEWE, ROBERT S 12d
18070401 FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE GOUGH, TIFFANY MAUREEN 19d
18927121 REAL-TIME CHEMICAL SCREENING METHOD USING LIVER ORGANOIDS FLUORESCENTLY LABELED WITH CYTOCHROME P450 1A1 ENZYME MISHRA, DEEPA —
18001333 ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING HAVLIN, ROBERT H —
17997151 SARS CORONAVIRUS 2 DIAGNOSTIC KIT INCLUDING RECEPTOR AND ANTIBODY BINDING TO SARS CORONAVIRUS 2 SPIKE PROTEIN BUCKMASTER, MARLENE VRENI —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18271640 NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF GRIZER, CASSANDRA SENN 9d
19000611 CATALYST FOR PRODUCING BASIC CHEMICAL RAW MATERIAL FROM DIESEL SINGH, PREM C —
18952945 ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS ROBINSON, MIKHAIL O'DONNEL —
18927121 REAL-TIME CHEMICAL SCREENING METHOD USING LIVER ORGANOIDS FLUORESCENTLY LABELED WITH CYTOCHROME P450 1A1 ENZYME MISHRA, DEEPA —
18753540 REACTOR FOR OXYGEN-FREE DIRECT CONVERSION OF METHANE AND METHOD FOR PREPARING ETHYLENE USING THE SAME NGUYEN, TAM M —
18687504 REACTOR FOR NON-OXIDATIVE DIRECT CONVERSION OF METHANE AND METHOD FOR PREPARING ETHYLENE AND AROMATIC COMPOUND BY USING SAME NGUYEN, TAM M —
18575726 POLYAMIC ACID AQUEOUS SOLUTION COMPOSITION MOORE, MARGARET G —
18378233 TRANSMISSIVE WAVELENGTH TUNABLE HYPERSPECTRAL FILTER USING LAYERED TWISTED LIQUID CRYSTAL THIN FILM NGUYEN, LAUREN —

Top Art Units

Art UnitApps
1771 2
1672 2
2812 1
2871 1
1723 1
1692 1
1626 1
1651 1
1623 1
1767 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19000611 CATALYST FOR PRODUCING BASIC CHEMICAL RAW MATERIAL FROM DIESEL SINGH, PREM C — §103 Non-Final OA — Pending Dec 23, 2024
18952945 ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS ROBINSON, MIKHAIL O'DONNEL — DP Non-Final OA — Pending Nov 19, 2024
18927121 REAL-TIME CHEMICAL SCREENING METHOD USING LIVER ORGANOIDS FLUORESCENTLY LABELED WITH CYTOCHROME P450 1A1 ENZYME MISHRA, DEEPA — §103§112DP Non-Final OA — Pending Oct 25, 2024
18797480 ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS JARRELL, NOBLE E — DP Non-Final OA — Pending Aug 07, 2024
18753540 REACTOR FOR OXYGEN-FREE DIRECT CONVERSION OF METHANE AND METHOD FOR PREPARING ETHYLENE USING THE SAME NGUYEN, TAM M 1771 §103 Non-Final OA — Pending Jun 25, 2024
18687504 REACTOR FOR NON-OXIDATIVE DIRECT CONVERSION OF METHANE AND METHOD FOR PREPARING ETHYLENE AND AROMATIC COMPOUND BY USING SAME NGUYEN, TAM M 1771 §103 Final Rejection — Pending Feb 28, 2024
18575726 POLYAMIC ACID AQUEOUS SOLUTION COMPOSITION MOORE, MARGARET G — §103 Non-Final OA — Pending Dec 29, 2023
18397073 VERTICAL ORGANIC TRANSISTOR AND METHOD OF MANUFACTURING THE SAME YI, CHANGHYUN 2812 §103Other Final Rejection — Pending Dec 27, 2023
18378233 TRANSMISSIVE WAVELENGTH TUNABLE HYPERSPECTRAL FILTER USING LAYERED TWISTED LIQUID CRYSTAL THIN FILM NGUYEN, LAUREN 2871 §103 Non-Final OA — Pending Oct 10, 2023
18242048 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME D'ANIELLO, NICHOLAS P 1723 §103 Final Rejection — Pending Sep 05, 2023
18271640 NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF GRIZER, CASSANDRA SENN 1672 §103§112 Final Rejection 9d Pending Jul 10, 2023
18011733 EFFICIENT DEPOLYMERIZATION METHOD OF POLYMERS COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF DOLETSKI, BLAINE G 1692 §103 Non-Final OA — Pending Dec 20, 2022
18001333 ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING HAVLIN, ROBERT H 1626 §102§103 Final Rejection — Pending Dec 09, 2022
18070401 FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE GOUGH, TIFFANY MAUREEN 1651 §101§103DP Final Rejection 19d Pending Nov 28, 2022
17997151 SARS CORONAVIRUS 2 DIAGNOSTIC KIT INCLUDING RECEPTOR AND ANTIBODY BINDING TO SARS CORONAVIRUS 2 SPIKE PROTEIN BUCKMASTER, MARLENE VRENI 1672 §102§112 Non-Final OA — Pending Oct 26, 2022
17594754 PHTHALAZINONE COMPOUNDS AND USE THEREOF SHTERENGARTS, SAMANTHA L 1623 §102 Final Rejection 14d Pending Oct 28, 2021
17419860 POLYMER COMPOSITE MATERIAL COMPRISING ARAMID NANOFIBER, AND METHOD FOR PREPARING SAME LOEWE, ROBERT S 1767 §103§112 Non-Final OA 12d Pending Jun 30, 2021

Managing Korea Research Institute of Chemical Technology's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month